NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(5.71%)
AUD 0.04
(5.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.95 Million | - | 958.76 Thousand | - | 33.84 Thousand |
| Cost of Revenue | 91.33 Thousand | 57.85 Thousand | 64.91 Thousand | 61.4 Thousand | 56.66 Thousand | 55.2 Thousand |
| Gross Profit | -91.33 Thousand | 4.89 Million | -64.91 Thousand | 897.36 Thousand | -56.66 Thousand | -21.35 Thousand |
| Operating Expenses | 1.96 Million | 6.06 Million | 10.43 Million | 4.16 Million | 2.88 Million | 1.59 Million |
| Selling, General and Administrative Expenses | 1.47 Million | 2.04 Million | 3.21 Million | 1.94 Million | 1.46 Million | 865.91 Thousand |
| Research and Development Expenses | 492.45 Thousand | 4.02 Million | 7.22 Million | 2.21 Million | 1.42 Million | 730.42 Thousand |
| Other Expenses | - | 4.95 Million | - | 1.01 Million | 40.54 Thousand | 33.84 Thousand |
| Cost and Expenses | 2.05 Million | 6.12 Million | 10.5 Million | 4.22 Million | 2.94 Million | 1.65 Million |
| Operating Income | -2.05 Million | -6.12 Million | -10.5 Million | -4.22 Million | -2.94 Million | -1.65 Million |
| Interest Expense | - | 4734.00 | - | 63.00 | 3417.00 | - |
| Income Tax Expense | -2.21 Million | -4.95 Million | -5.00 | 3.00 | -1.00 | -33.84 Thousand |
| Earnings before Tax | -1.88 Million | -6.02 Million | -10.43 Million | -3.17 Million | -2.86 Million | -1.69 Million |
| Net Income | 324.21 Thousand | -1.06 Million | -10.43 Million | -3.17 Million | -2.86 Million | -1.65 Million |
| Earnings Per Share Basic | 0.00 | -0.01 | -0.07 | -0.02 | -0.04 | -0.02 |
| Earnings Per Share Diluted | 0.00 | -0.01 | -0.07 | -0.02 | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 144.5 Million | 143.47 Million | 143.47 Million | 143.47 Million | 78.38 Million | 71.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 144.5 Million | 143.47 Million | 143.47 Million | 143.47 Million | 78.38 Million | 71.52 Million |
| Gross Margin | - | 0.99 | - | 0.94 | - | -0.63 |
| EBIT Margin | - | -1.22 | - | -4.34 | - | -47.16 |
| Profit Margin | - | -0.22 | - | -3.31 | - | -49.01 |
| EBITDA | -1.79 Million | -5.96 Million | -10.37 Million | -3.11 Million | -2.81 Million | -1.59 Million |
| Earnings Before Tax Margin | - | -1.24 | - | -4.41 | - | -48.79 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 4.95 Million | 3.79 Million | 1.15 Million |
| Cost of Revenue | 48.9 Thousand | 91.33 Thousand | 42.43 Thousand | 57.85 Thousand | 27.85 Thousand | 30 Thousand |
| Gross Profit | -48.9 Thousand | -91.33 Thousand | -42.43 Thousand | 4.89 Million | 3.76 Million | 1.12 Million |
| Operating Expenses | 696.24 Thousand | 1.96 Million | 1.26 Million | 6.06 Million | 1.82 Million | 4.24 Million |
| Selling, General and Administrative Expenses | 451.02 Thousand | - | 1.02 Million | - | 707.24 Thousand | 1.33 Million |
| Research and Development Expenses | 245.22 Thousand | - | 247.23 Thousand | - | 1.11 Million | 2.91 Million |
| Other Expenses | - | - | - | 4.95 Million | - | - |
| Cost and Expenses | 745.15 Thousand | 2.05 Million | 1.31 Million | 6.12 Million | 1.84 Million | 4.27 Million |
| Operating Income | -745.15 Thousand | -2.05 Million | -1.31 Million | -6.12 Million | -1.84 Million | -4.27 Million |
| Interest Expense | - | - | - | 4734.00 | - | - |
| Income Tax Expense | 4.00 | -2.21 Million | -1.00 | -4.95 Million | -2.00 | -2.00 |
| Earnings before Tax | 1.55 Million | -1.88 Million | -1.23 Million | -6.02 Million | 1.99 Million | -3.05 Million |
| Net Income | 1.55 Million | 324.21 Thousand | -1.23 Million | -1.06 Million | 1.99 Million | -3.05 Million |
| Earnings Per Share Basic | 0.01 | - | -0.01 | - | 0.01 | -0.02 |
| Earnings Per Share Diluted | 0.01 | - | -0.01 | - | 0.01 | -0.02 |
| Weighted Average Shares Outstanding | 144.6 Million | 144.5 Million | 144.6 Million | 143.47 Million | 143.47 Million | 143.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 144.6 Million | 144.5 Million | 144.6 Million | 143.47 Million | 143.47 Million | 143.47 Million |
| Gross Margin | - | - | - | 0.99 | 0.99 | 0.97 |
| EBIT Margin | - | - | - | - | -0.48 | -3.66 |
| Profit Margin | - | - | - | -0.22 | 0.52 | -2.64 |
| EBITDA | -696.24 Thousand | - | -1.26 Million | - | -1.82 Million | -4.24 Million |
| Earnings Before Tax Margin | - | - | - | -1.24 | -0.49 | -3.69 |
INSECTICID
TCNT
RCI-A
BIGG
029460
1925